2008 Lung Cancer Research Foundation Annual Grant Program
Jorge Jacoby, PhD
University of Texas MD Anderson Cancer Center
Research Project:
Study of HIF-1 Alpha as a Target for PX-478, a new drug for Lung Cancer
Summary:
A new drug in early clinical trials for lung cancer will be studied in further detail to evaluate its action on lung cancer cells as well as identifying potential ways to determine which patients could be predicted as best candidates for the drug.